Home › NDC Lookup › RxCUI directory › RxCUI 2602366

4 ML pemetrexed 25 MG/ML Injection — RxCUI 2602366

RxNorm drug concept · Semantic clinical drug
RxCUI 2602366 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2602366
Official name4 ML pemetrexed 25 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspemetrexed (as monohydrate) 100 MG per 4 ML Injection; PEMEtrexed 100 MG in 4 ML Injection
FDA products mapped12
Package NDCs mapped11
Reported Medicaid activity (SDUD)22 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pemetrexed Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats non-squamous non-small cell lung cancer and malignant pleural mesothelioma. Depending on your situation, it may be given alone or with cisplatin, or with pembrolizumab an...
  • It is given through an IV over about 10 minutes, usually once every 21 days. You also need daily folic acid, a vitamin B12 shot, and dexamethasone around each treatment. These help...
  • How will I get it, and what else do I need to take?
  • Tiredness, nausea and loss of appetite are common. Vomiting, mouth sores, constipation, diarrhea, rash and low blood counts can also happen, depending on what you take it with. You...
📖 Read our full Pemetrexed Injection guide →

🕸️ Concept Web — How 4 ML pemetrexed 25 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 4 ML pemetrexed 25 MG/ML Injection RxCUI 2602366

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pemetrexed 68446
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pemetrexed Injection 1728071
    • Pemetrexed Injectable Product 1161384
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Pemetrexed 25 MG/ML 2590670

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pemetrexed 25 MG/ML SCDC · 2590670
  • Pemetrexed Injection SCDF · 1728071
  • Pemetrexed Injectable Product SCDG · 1161384

📦 FDA Products & Package NDCs

12 products · 11 package NDCs
11 package NDCs map to RxCUI 2602366 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00409-0004-04 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0004-04) / 40 mL in 1... PEMETREXED Hospira, Inc. 2023-02-01
00409-0020-02 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0020-02) / 4 mL in 1... PEMETREXED Hospira, Inc. 2023-02-01
00409-0021-03 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0021-03) / 20 mL in 1... PEMETREXED Hospira, Inc. 2023-02-01
00409-1045-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1045-01) / 4 mL in 1... PEMETREXED Hospira, Inc. 2022-06-27
00409-2188-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-2188-01) / 20 mL in 1... PEMETREXED Hospira, Inc. 2022-06-27
00409-3532-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-3532-01) / 40 mL in 1... PEMETREXED Hospira, Inc. 2022-06-27
00480-4514-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4514-01) / 20 mL in 1... Pemetrexed Teva Pharmaceuticals, Inc. 2022-05-31
00480-4515-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4515-01) / 40 mL in 1... Pemetrexed Teva Pharmaceuticals, Inc. 2022-05-31
00480-4516-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4516-01) / 4 mL in 1... Pemetrexed Teva Pharmaceuticals, Inc. 2022-06-01
00781-3518-76 1 VIAL in 1 CARTON (0781-3518-76) / 4 mL in 1 VIAL Pemetrexed Sandoz Inc. 2022-06-08
00781-3519-90 1 VIAL in 1 CARTON (0781-3519-90) / 20 mL in 1 VIAL Pemetrexed Sandoz Inc. 2022-06-08
Observed labelers: Hospira, Inc. (6) · Teva Pharmaceuticals, Inc. (3) · Sandoz Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9294 Inj pemetrexed, hospira 10mg 6 CMS
J9314 Inj pemetrexed (teva) 10mg 3 CMS
J9297 Inj pemetrexed (sandoz) 10mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.